Vectura receives $2.5 m milestone payment for tEuropean regulatory submission of QVM149
Vectura announced it will receive a $2.5million milestone payment under an exclusive licence agreement with Novartis. The payment was triggered following acceptance of Novartis' valid MAA by the EU Regulatory Authorities for the regulatory approval of QVM149. May 24, 2019